Compare Freeport-McMoRan Inc (FCX) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freeport-McMoRan Inc vs 10X Genomics Inc — how do they compare? Freeport-McMoRan Inc trades at $59.26 (market cap $87.65B), while 10X Genomics Inc trades at $45.49 (market cap $5.81B). The key difference: Freeport-McMoRan Inc is far larger — about 15.1× 10X Genomics Inc's market cap, and Freeport-McMoRan Inc pays a 0.98% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| FCX | TXG | |
|---|---|---|
Market Cap | $87.65B | $5.81B |
Sector | Basic Materials | Health |
52-Week High | $71.73 | $45.80 |
52-Week Low | $35.34 | $11.34 |
Enterprise Value | $94.31B | $5.35B |
Dividend Yield | 0.98% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Freeport-McMoRan (FCX) trades at $61.97, up 3.33% with a bearish technical signal despite three consecutive quarterly earnings beats. The copper miner shows improving fundamentals with revenue growth to $25.92B and net income of $2.20B in 2025, supported by strong copper demand. Analyst consensus remains bullish with a $72.94 price target, though the stock faces technical resistance near $63-64 levels.
FCX presents a compelling value proposition with expanding profit margins and strategic positioning in the copper market, though investors face volatility risks from commodity price fluctuations and ongoing negative cash flow trends. The company's expansion pipeline and dividend payments provide additional shareholder value drivers.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
